Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.
about
Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy.The role of health economics and outcomes research in health care reform in ChinaAdjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysis.Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patients.
P2860
Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Cost-utility analysis of the n ...... s in Oncology: Gastric Cancer.
@en
Cost-utility analysis of the n ...... l Comprehensive Cancer Network
@nl
type
label
Cost-utility analysis of the n ...... s in Oncology: Gastric Cancer.
@en
Cost-utility analysis of the n ...... l Comprehensive Cancer Network
@nl
prefLabel
Cost-utility analysis of the n ...... s in Oncology: Gastric Cancer.
@en
Cost-utility analysis of the n ...... l Comprehensive Cancer Network
@nl
P2093
P2860
P1433
P1476
Cost-utility analysis of the n ...... s in Oncology: Gastric Cancer.
@en
P2093
Chen Gannong
Ouyang Lihui
Peng Liubao
Tan Chongqing
Wan Xiaomin
Wang Siying
Zeng Xiaohui
Zhao Ziying
P2860
P2888
P304
P356
10.1007/S40273-013-0065-2
P577
2014-03-01T00:00:00Z